Lei Tao

Years Active: 2023-2024
Publications (10 Years): 5

This page only lists publications with an associated author ORCID identifier.

Publications

Yue Zhou, Lei Tao, Jiahao Qiu, Jing Xu, Xinyu Yang, Yu Zhang, Xinyu Tian, Xinqi Guan, Xiao-Bo Cen, Yinglan Zhao
Tumor biomarkers for diagnosis, prognosis and targeted therapy. Signal transduction and targeted therapy 9 (1) (2024)
Yue Zhou, Lei Tao, Jiahao Qiu, Jing Xu, Xinyu Yang, Yu Zhang, Xinyu Tian, Xinqi Guan, Xiao-Bo Cen, Yinglan Zhao
Tumor biomarkers for diagnosis, prognosis and targeted therapy. Signal transduction and targeted therapy 9 (1) (2024)
Yue Zhou, Lei Tao, Jiahao Qiu, Jing Xu, Xinyu Yang, Yu Zhang, Xinyu Tian, Xinqi Guan, Xiao-Bo Cen, Yinglan Zhao
Tumor biomarkers for diagnosis, prognosis and targeted therapy. Signal transduction and targeted therapy 9 (1) (2024)
Yue Zhou, Lei Tao, Jiahao Qiu, Jing Xu, Xinyu Yang, Yu Zhang, Xinyu Tian, Xinqi Guan, Xiao-Bo Cen, Yinglan Zhao
Tumor biomarkers for diagnosis, prognosis and targeted therapy. Signal transduction and targeted therapy 9 (1) (2024)
Lei Tao, Yue Zhou, Xiangyu Pan, Yuan Luo, Jiahao Qiu, Xia Zhou, Zhiqian Chen, Yan Li, Lian Xu, Yang Zhou, Zeping Zuo, Chunqi Liu, Liang Wang, Xiaocong Liu, Xinyu Tian, Na Su, Zhengnan Yang, Yu Zhang, Kun Gou, Na Sang, Huan Liu, Jiao Zou, Yuzhou Xiao, Xi Zhong, Jing Xu, Xinyu Yang, Kai Xiao, Yanyang Liu, Sheng-Yong Yang, Yong Peng, Junhong Han, Xiao-Bo Cen, Yinglan Zhao
Repression of LSD1 potentiates homologous recombination-proficient ovarian cancer to PARP inhibitors through down-regulation of BRCA1/2 and RAD51. Nature communications 14 (1) (2023)

Lei Tao.css-eqlu8i{font-size:small;padding-left:4px;}